Results 41 to 50 of about 528,622 (127)

Additional file 1 of Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study

, 2023
Additional file 1. Table S1a: Total bilirubin concentration (mg/dL) pre- and post-Cytosorb® at different timepoints. Table S1b: Conjugated bilirubin concentration (mg/dL) pre- and post-Cytosorb® at different timepoints.
Katharina Habler (1409287), Clara Isabell Brozat (17369240), Uwe Liebchen (9677184), Michael Paal (3024075), Antonia Greimel (17369231), Michael Zoller (4530031), Christina Scharf (4530028), Nils Maciuga (17369237), Michael Vogeser (364534), Caroline Gräfe (17369234), Felix L. Happich (17369243), Sandra Frank (10029431)   +11 more
core   +1 more source

Immunmodulation und funktionale Charakterisierung der durch CytoSorb® hämadsorbierten Proteine auf den Schaden mikrovaskulärer Endothelzellen

, 2022
Blutreinigungsverfahren werden in klinischen Studien angewandt, um Patienten unter anderem im septischen Schock zu behandeln. Dabei wird versucht über die Adsorption von Zytokinen und danger associated moleculare patterns (DAMPs) die Funktion der ...
Denzinger, Maximilian Tobias
core   +1 more source

Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia

Frontiers in Surgery, 2021
Hyperbilirubinaemia has been shown to compromise wound healing in severely burned patients. The therapy options for patients with impairment of wound healing and subsequent severe liver dysfunction are limited. A novel extracorporeal treatment, CytoSorb®
Katarzyna Rachunek, Maja Krause, Johannes Tobias Thiel, Jonas Kolbenschlag, Adrien Daigeler, Andreas Bury   +5 more
doaj   +1 more source

Cytosorb® haemoadsorption: a potential game changer for patients needing myocardial surgical revascularisation [PDF]

, 2021
Cytosorb, an extracorporeal blood purification system, utilises the principles of haemoadsorption to remove low molecular weight substances from the blood, including multiple cytokines such as interleukin (IL)-1b, IL-6, IL-8, and tumour necrosis factor-α,
Marczin, Nandor, Stock, Ulrich A, Umakumar, Kabeer, Ng Yin Ling, Clarissa, Raja, Shahzad G, de Waal, Eric EC, Moss, Louise, Shahzad G. Raja, Nandor Marczin, Ulrich A. Stock, Clarissa Ng Yin Ling, Louise Moss, Eric E.C. de Waal, Kabeer Umakumar   +13 more
core   +1 more source

Post VV-ECMO Weaning Hyperinflammation—Can Prophylactic Hemoadsorption Treatment Prevent Complications?

Medicina, 2023
Acute respiratory distress syndrome (ARDS) is a severe clinical condition characterized by acute respiratory failure and a high mortality risk despite conventional mechanical ventilatory support.
Pedja Kovacevic, Sasa Dragic, Milka Jandric, Danica Momcicevic, Sandra Topolovac, Vedrana Malesevic, Tijana Kovacevic, Marijana Matejic-Spasic, Tanja Knezevic, Biljana Zlojutro   +9 more
doaj   +1 more source

Applications of Cytosorb in clinical practice [PDF]

, 2021
Introduction and objective. Cytososorb is haemadsorption device approved in the European Union in 2011 for cytokine adsorption. Recently, in 2018, new indications for the device use have been added, including bilirubin and myoglobin removal.
Borys, M., Kutnik, P.
core   +1 more source

Pharmacokinetics of immunosuppressive agents during hemoperfusion in a sheep model

Frontiers in Medicine, 2023
IntroductionHemoadsorption shows promising signals in organ preservation and post lung transplantation. However, its potential impact on the pharmacokinetics of immunosuppressant drugs (ID) is still unknown.MethodsIn this interventional study, CytoSorb ...
Bettina Leber, Uwe Liebchen, Lisa Rohrhofer, Jennifer Weber, Teresa Klaus, Joerg Scheier, Robert Sucher, Philipp Stiegler   +7 more
doaj   +1 more source

Initial experience with CytoSorb therapy in patients receiving left ventricular assist devices [PDF]

, 2022
BACKGROUND: The use of left ventricular assist devices (LVAD) in patients with advance heart failure is still associated with an important risk of immune dysregulation and infections.
Jef Van den Eynde, Peter Luedike, Thomas Chrosch, Markus Kamler, Alexander Weymann, Van den Eynde, Jef, Konstantin Zhigalov, Nikolaus Pizanis, Bastian Schmack, Achim Koch, Lukas Goerdt, Arian Arjomandi Rad, Goerdt, Lukas, Robert Vardanyan, Pizanis, Nikolaus, Kamler, Markus, Arjang Ruhparwar, Michel Pompeu Barros Oliveira Sá, Luedike, Peter, Arjomandi Rad, Arian; id_orcid, Alina Zubarevich, Zubarevich, Alina, Weymann, Alexander, Koch, Achim, Chrosch, Thomas, Zhigalov, Konstantin, Ruhparwar, Arjang, Vardanyan, Robert, Sá, Michel Pompeu Barros Oliveira, Schmack, Bastian, Rad, Arian Arjomandi   +30 more
core   +1 more source

Experience of using an extracorporeal cytokine hemoadsorber (CytoSorb®) in systemic inflammatory response syndrome after heart transplantation

Indian Journal of Transplantation, 2020
Heart transplantation is well-established and considered the most effective therapy for patients with end-stage heart failure. Systemic inflammatory response syndrome (SIRS) and renal dysfunction after heart transplantation are commonly experienced ...
Kewal Krishan, Rahul Dutta, Rajesh Chand, Rajneesh Malhotra   +3 more
doaj   +1 more source

CytoSorb®-Anwendung : Assoziation mit klinischem Outcome in der Herzchirurgie [PDF]

Das Auftreten eines systemisch inflammatorischen Response-Syndroms (SIRS) im Rahmen eines herzchirurgischen Eingriffes steht bei Persistenz im Zusammenhang mit einer erhöhten Morbidität und Mortalität.
Biehler, Natalie
core   +1 more source